Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer
JCO Oncology Practice · 2025-03 · 21 (3) · 333-340
DOI: 10.1200/op.24.00159 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, 2025-03. Verfasst von Jacob B Leary und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, WA. Hauptthemen laut MEDLINE: Colonic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE Rising rates of early-onset colon cancer (EOCC) present challenges in deciding how to optimally treat patients. Although standard of care for stage II CC is surgical resection, adding chemotherapy for high-risk disease, evidence suggests treatment selection may differ by age. We investigated whether adjuvant chemotherapy (AC) administration rates differ between patients with early- and later-onset stage II CC. METHODS Data originated from the nationwide Flatiron Health electronic health record (EHR)–derived deidentified database spanning January 1, 2003, to August 1, 2021. Adults with stage II CC were grouped as age 18-49 years (EOCC) and those age 50 years or older (later-onset colon cancer [LOCC]). Demographics, Eastern Cooperative Oncology Group score, tumor stage and site, and chemotherapy were included. Primary outcomes included rates of AC administration by age and ethnicity; secondary outcomes included overall survival (OS) and time to metastatic disease (TTMD). Univariate and multivariable logistic regression models evaluated relationships between chemotherapy administration, age, and ethnicity, adjusting for significant covariates. RESULTS One thousand sixty-five patients were included. Median age of patients with EOCC was 45.0 years versus 69.0 years for patients with LOCC. Adjusted multivariate analysis showed patients with EOCC received AC significantly more often than patients with LOCC. Non-Hispanic patients received AC at significantly lower rates than Hispanic patients in both cohorts. Subanalysis of stage IIA patients showed that patients with EOCC were more likely to receive AC than patients with LOCC. No significant differences in OS or TTMD were observed by age regardless of AC administration in stage II overall; however, patients with stage IIA EOCC receiving AC had significantly longer TTMD than those not receiving AC. CONCLUSION AC was given preferentially in stage II EOCC, even in stage IIA, despite deviation from guidelines. This may expose low-risk patients to unnecessary toxicities and suggests bias toward treating younger patients more aggressively, despite unclear evidence for better outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, University of Washington, Seattle, WA.
- Biostatistics Shared Resource, University of Colorado Cancer Center, Aurora, CO.
- Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO.
- Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO.
ORCID-Profile: Jacob B Leary, Junxiao Hu, Sunnie Kim, Robert Lentz, Tyler Friedrich, Whitney Herter, Wells A Messersmith, Christopher H Lieu
Förderung
- NCI NIH HHS
Zitieren
APA
Leary, J. B., Hu, J., Leal, A., Davis, S. L., Kim, S., Lentz, R., Friedrich, T., Herter, W., Messersmith, W. A., & Lieu, C. H. (2025). Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer. JCO Oncology Practice, 21(3), 333-340. https://doi.org/10.1200/op.24.00159
Vancouver
Leary JB, Hu J, Leal A, Davis SL, Kim S, Lentz R, et al. Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer. JCO Oncology Practice. 2025;21(3):333-340. doi:10.1200/op.24.00159
BibTeX
@article{Leary2025,
author = {Leary, Jacob B and Hu, Junxiao and Leal, Alexis and Davis, S Lindsey and Kim, Sunnie and Lentz, Robert and Friedrich, Tyler and Herter, Whitney and Messersmith, Wells A and Lieu, Christopher H},
title = {Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer},
journal = {JCO Oncology Practice},
year = {2025},
volume = {21},
number = {3},
pages = {333--340},
doi = {10.1200/op.24.00159}
}
EUVIMED